ACORDA - Building Confidence Beyond AMPYRA! - new market research report published
ACORDA - Building Confidence Beyond AMPYRA! - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-14 09:14:03
Acorda Therapeutics (ACOR) reported 4Q/FY12 results with a decent growth in sales of marketed products and promises to strengthen its pipeline and focus on unmet needs in CNS diseases. Growth in AMPYRA´s Sales reflects ACOR´s concerted marketing efforts which have helped improve awareness amongst physicians and pts.
Potential label expansion of AMPYRA (POC data in 2Q13) and pipeline beyond AMPYRA could lead to the next driver to the stock. Successful development of AMPYRA, as well as additional pipeline products makes ACOR an attractive target for...
For more details, please read our report released on 15th February 2013 on ACOR titled "Building Confidence Beyond AMPYRA!"
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.